185 related articles for article (PubMed ID: 10226867)
1. Bradykinin-dependent cardioprotective effects of losartan against ischemia and reperfusion in rat hearts.
Zhu P; Zaugg CE; Hornstein PS; Allegrini PR; Buser PT
J Cardiovasc Pharmacol; 1999 May; 33(5):785-90. PubMed ID: 10226867
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of the angiotensin-converting enzyme inhibitor captopril on postischemic myocardial damage in perfused rat heart.
Takeda H; Haneda T; Kikuchi K
Jpn Circ J; 1997 Aug; 61(8):687-94. PubMed ID: 9276774
[TBL] [Abstract][Full Text] [Related]
3. Effects of the insurmountable angiotensin AT1 receptor antagonist candesartan and the surmountable antagonist losartan on ischemia/reperfusion injury in rat hearts.
Wang QD; Sjöquist PO
Eur J Pharmacol; 1999 Sep; 380(1):13-21. PubMed ID: 10513555
[TBL] [Abstract][Full Text] [Related]
4. Myocardial protection by preconditioning of heart with losartan, an angiotensin II type 1-receptor blocker: implication of bradykinin-dependent and bradykinin-independent mechanisms.
Sato M; Engelman RM; Otani H; Maulik N; Rousou JA; Flack JE; Deaton DW; Das DK
Circulation; 2000 Nov; 102(19 Suppl 3):III346-51. PubMed ID: 11082412
[TBL] [Abstract][Full Text] [Related]
5. Critical role of AT1 receptor expression after ischemia/reperfusion in isolated rat hearts: beneficial effect of antisense oligodeoxynucleotides directed at AT1 receptor mRNA.
Yang BC; Phillips MI; Zhang YC; Kimura B; Shen LP; Mehta P; Mehta JL
Circ Res; 1998 Sep; 83(5):552-9. PubMed ID: 9734478
[TBL] [Abstract][Full Text] [Related]
6. MK-954 (losartan potassium) exerts endothelial protective effects against reperfusion injury: evidence of an e-NOS mRNA overexpression after global ischemia.
Barsotti A; Di Napoli P; Taccardi AA; Spina R; Stuppia L; Palka G; Barbacane RC; De Caterina R; Conti P
Atherosclerosis; 2001 Mar; 155(1):53-9. PubMed ID: 11223426
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotection with angiotensin converting enzyme inhibitor and angiotensin II type 1 receptor antagonist is not abolished by nitric oxide synthase inhibitor in ischemia-reperfused rabbit hearts.
Kawabata H; Ryomoto T; Ishikawa K
Hypertens Res; 2001 Jul; 24(4):403-9. PubMed ID: 11510753
[TBL] [Abstract][Full Text] [Related]
8. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
Hu K; Gaudron P; Anders HJ; Weidemann F; Turschner O; Nahrendorf M; Ertl G
Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525
[TBL] [Abstract][Full Text] [Related]
9. Role of cardiac ATP-sensitive K+ channels induced by angiotensin II type 1 receptor antagonist on metabolism, contraction and relaxation in ischemia-reperfused rabbit heart.
Kawabata H; Ryomoto T; Ishikawa K
Jpn Circ J; 2001 May; 65(5):451-6. PubMed ID: 11348052
[TBL] [Abstract][Full Text] [Related]
10. Opposite effects of angiotensin AT1 and AT2 receptor antagonists on recovery of mechanical function after ischemia-reperfusion in isolated working rat hearts.
Ford WR; Clanachan AS; Jugdutt BI
Circulation; 1996 Dec; 94(12):3087-9. PubMed ID: 8989113
[TBL] [Abstract][Full Text] [Related]
11. AT(1) and AT(2) receptor expression and blockade after acute ischemia-reperfusion in isolated working rat hearts.
Xu Y; Kumar D; Dyck JR; Ford WR; Clanachan AS; Lopaschuk GD; Jugdutt BI
Am J Physiol Heart Circ Physiol; 2002 Apr; 282(4):H1206-15. PubMed ID: 11893553
[TBL] [Abstract][Full Text] [Related]
12. Bradykinin accounts for improved postischemic function and decreased glutathione release of guinea pig heart treated with the angiotensin-converting enzyme inhibitor ramiprilat.
Massoudy P; Becker BF; Gerlach E
J Cardiovasc Pharmacol; 1994 Apr; 23(4):632-9. PubMed ID: 7516015
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotective effect of the angiotensin II type 1 receptor antagonist TCV-116 on ischemia-reperfusion injury.
Yoshiyama M; Kim S; Yamagishi H; Omura T; Tani T; Yanagi S; Toda I; Teragaki M; Akioka K; Takeuchi K
Am Heart J; 1994 Jul; 128(1):1-6. PubMed ID: 8017262
[TBL] [Abstract][Full Text] [Related]
14. Effects of the angiotensin II subtype 1 receptor antagonist losartan on functional recovery of isolated rat hearts undergoing global myocardial ischemia-reperfusion.
Flynn JD; Akers WS
Pharmacotherapy; 2003 Nov; 23(11):1401-10. PubMed ID: 14620386
[TBL] [Abstract][Full Text] [Related]
15. Quinaprilat during cardioplegic arrest in the rabbit to prevent ischemia-reperfusion injury.
Korn P; Kröner A; Schirnhofer J; Hallström S; Bernecker O; Mallinger R; Franz M; Gasser H; Wolner E; Podesser BK
J Thorac Cardiovasc Surg; 2002 Aug; 124(2):352-60. PubMed ID: 12167796
[TBL] [Abstract][Full Text] [Related]
16. Effect of angiotensin converting enzyme inhibition with quinaprilat on the ischaemic and reperfused myocardium.
Cargnoni A; Boraso A; Scotti C; Ghirardelli N; Benigno M; Bernocchi P; Pedersini P; Ferrari R
J Mol Cell Cardiol; 1994 Jan; 26(1):69-86. PubMed ID: 8196071
[TBL] [Abstract][Full Text] [Related]
17. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
Hartman JC
Ann Thorac Surg; 1995 Sep; 60(3):789-92. PubMed ID: 7545893
[TBL] [Abstract][Full Text] [Related]
18. Effect of an endothelin receptor antagonist and an angiotensin converting enzyme inhibitor on metabolism and contraction in the ischemic and reperfused rabbit heart.
Kawabata H; Ryomoto T; Ishikawa K
Jpn Circ J; 1999 Oct; 63(10):770-4. PubMed ID: 10553919
[TBL] [Abstract][Full Text] [Related]
19. Local inhibition of bradykinin degradation in ischemic hearts.
Linz W; Martorana PA; Schölkens BA
J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370
[TBL] [Abstract][Full Text] [Related]
20. Intermittent losartan administration triggers cardiac post-conditioning in isolated rat hearts: role of BK2 receptors.
Sgarra L; Leo V; Addabbo F; Iacobazzi D; Carratù MR; Montagnani M; Potenza MA
PLoS One; 2014; 9(2):e88542. PubMed ID: 24520397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
